MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-25-2026
Armata Pharmaceuticals Current Ratio 2011-2026 | ARMP
Annual Current Ratio Armata Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.26 | 0.643 | 0.754 | 1.6 | 1.57 | 1.62 | 1.36 | 3.27 | 2.74 | 1.78 | 4.2 | 3.76 | 9.56 | 0.273 | 1.07 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.56 | 0.26 | 2.3 |
Quarterly Current Ratio Armata Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.48 | 0.54 | 0.62 | 0.64 | 0.66 | 0.7 | 0.68 | 0.75 | 0.9 | 1.23 | 1.26 | 1.6 | 1.96 | 2.12 | 2.33 | 1.57 | 2.26 | 2.46 | 2.81 | 1.91 | 1.91 | 1.91 | 1.91 | 2.34 | 2.34 | 2.34 | 2.34 | 2.12 | 2.12 | 2.12 | 3.48 | 3.27 | 3.27 | 3.27 | 3.27 | 2.15 | 2.15 | 2.15 | 2.15 | 4.57 | 4.57 | 4.57 | 4.57 | 1.23 | 1.23 | 1.23 | 1.23 | 0.65 | 0.65 | 0.65 | 0.65 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.57 | 0.48 | 1.96 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M |  USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
0.762 | - | - | $ 8.42 M | USA |
 |
Aptorum Group Limited
APM
|
3.81 | $ 0.88 | -1.73 % | $ 6.47 M | China |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
2.61 | $ 22.48 | 0.81 % | $ 3.73 B | USA |
 |
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M |  Israel |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.0929 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | USA |
 |
Cara Therapeutics
CARA
|
2.88 | - | -3.03 % | $ 260 M | USA |
 |
CASI Pharmaceuticals
CASI
|
4.56 | - | - | $ 35.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
3.56 | - | -0.88 % | $ 598 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.378 | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
7.95 | $ 101.39 | -0.66 % | $ 27.2 B | Germany |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |
 |
Avenue Therapeutics
ATXI
|
2.67 | - | -52.27 % | $ 4.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
0.827 | $ 4.06 | -0.98 % | $ 434 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 23.08 | -1.45 % | $ 2.94 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.49 | 4.58 % | $ 397 M | Britain |
 |
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 2.92 | -0.14 % | $ 4.81 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
ContraFect Corporation
CFRX
|
0.636 | - | -5.16 % | $ 5.39 M | USA |
 |
Cardiff Oncology
CRDF
|
3.75 | $ 1.7 | -1.45 % | $ 114 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
0.878 | - | - | $ 1.2 B | USA |
 |
BioXcel Therapeutics
BTAI
|
0.32 | $ 1.06 | -3.21 % | $ 12.9 M | USA |
 |
Cabaletta Bio
CABA
|
3.11 | $ 2.83 | -2.92 % | $ 284 M | USA |